Fundraising Fox
/People
Sign in

Mathias Frederiksen

Investor

Principal at Novartis Venture Fund

Basel, Switzerland

Writes $5M – $10M checks · typically $7.5M

Find your path to Mathias

699 people in our graph can introduce you to Mathias.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Beat Steffen to introduce you to Mathias

You →Beat · together at UZH Life Sciences Fund (2022–2026) →Mathias

Ask Jamie Chen to introduce you to Mathias

You →Jamie · 6 people · together at Novartis Venture Fund →Mathias

Ask Sam Okafor to introduce you to Mathias

You →Sam · together at Fundamentalpharma →Mathias

Sign up to find every way you can get introduced to Mathias

  • Your email: the people you already email who know Mathias
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Mathias
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Mathias Frederiksen is a Principal at the Novartis Venture Fund, based in Basel. Before joining NVF, he was a group leader in Novartis R&D, where his work covered neuroscience-focused medicinal chemistry, chemical genomics, and target discovery, with a focus on epigenetic dysregulation in disease, and he served on the portfolio management and strategy team. He holds a BSc in Chemistry from Mount Allison University, a PhD in Chemistry from Imperial College London, and completed a postdoctorate at Stanford University.

Experience

  1. Novartis Venture FundPrincipalcurrent2023 — presentBasel, Switzerland
  2. Novartis Venture FundAssociate2022 — 2023Basel, Switzerland
  3. AravaxDirector Board of Directorscurrent2026 — present
  4. NRG TherapeuticsBoard Observercurrent2025 — presentStevenage, England, United Kingdom
  5. Averna TherapeuticsBoard Observercurrent2024 — presentBoston, Massachusetts, United States
  6. UZH Life Sciences FundInvestment Managercurrent2022 — presentZurich, Switzerland
  7. LoQus23 Therapeutics LtdBoard Observercurrent2022 — presentCambridge, England, United Kingdom
  8. FundaMental PharmaDirector Board of Directors2023 — 2025Heidelberg, Baden-Württemberg, Germany
  9. Para TherapeuticsBoard Observer2023 — 2025San Francisco Bay Area
  10. Novartis Institutes for BioMedical Research (NIBR)Associate Director and Group Leader Chomatin Chemical Biology2020 — 2022Basel Area, Switzerland
  11. Novartis Institutes for BioMedical Research (NIBR)Senior Investigator II2018 — 2020Basel Area, Switzerland
  12. Novartis Institutes for BioMedical Research (NIBR)Senior Investigator I2014 — 2018Basel Area, Switzerland
  13. Novartis Institutes for BioMedical Research (NIBR)Investigator III2010 — 2014
  14. Novartis Institutes for BioMedical Research (NIBR)Research Investigator II2007 — 2009
  15. Novartis Institutes for BioMedical Research (NIBR)Research Investigator I2005 — 2007
  16. Stanford UniversityPost-doctoral Research Investigator2003 — 2004
  17. Imperial College LondonPhD Candidate1998 — 2002

Skills & more

Start-up Ventures4Corporate Venture Capital5Company build3Venture CapitalVenture FinancingFinanceEpigenetics11Medicinal Chemistry80Drug Design68Organic Synthesis47Drug Discovery99Life Sciences20
+12 moreProteomicsCell Based AssaysOrganic ChemistrySignal TransductionTarget IdentificationLifesciencesPharmaceutical IndustryLead ChangeAssay DevelopmentDrug DevelopmentCellGPCRs

Languages English · French · German · Norwegian

From Mathias's professional profile.

Investments

Investor

FundaMental Pharma

Per curated public sources.

Colleagues at Novartis Venture Fund

Adam Cotton
Principal at the Novartis Venture Fund
Anís
Head of Scoping, Pharma at Deep Science Ventures
Anja Koenig
Global Head of NVF at Novartis Venture Fund
Bart Dzikowski
Managing Director, Head of Transactions & Legal at Novartis Venture Fund
Beat Steffen
Managing Director at Novartis Venture Fund
Campbell Murray
Advisor
Christoph Meier
Investor at Novartis Venture Fund
Elaine Jones
Investor at Novartis Venture Fund

Frequently asked questions

Who is Mathias Frederiksen?
Mathias Frederiksen is a Principal at the Novartis Venture Fund, based in Basel. Before joining NVF, he was a group leader in Novartis R&D, where his work covered neuroscience-focused medicinal chemistry, chemical genomics, and target discovery, with a focus on epigenetic dysregulation in disease, and he served on the portfolio management and strategy team. He holds a BSc in Chemistry from Mount Allison University, a PhD in Chemistry from Imperial College London, and completed a postdoctorate at Stanford University.
Where does Mathias Frederiksen work?
Mathias Frederiksen is Principal at Novartis Venture Fund.
What check size does Mathias Frederiksen write?
Mathias Frederiksen typically writes checks of $5M – $10M.
What companies has Mathias Frederiksen invested in?
Investments tracked here include FundaMental Pharma.
Where did Mathias Frederiksen go to school?
Mathias Frederiksen studied at Stanford University (Post-Doc, Chemistry); Imperial College London (PhD, Synthetic Organic Chemistry); Mount Allison University (B.Sc, Chemistry).

Same school

Shared employers